tirzepatide approved for teens GLP-1 Agonist Scripts Jumped 600% Teens, Young Adults Since 2020 Kids approved for weight loss

Small-molecule oral drugs change that math: they are cheaper to manufacture, easier to store, and remove the injection barrier that keeps some people off treatment entirely

Please ask your Patient Support agent for more information

This enzyme specifically targets and neutralizes lipid hydroperoxides, repairing the oxidative damage to the mitochondrial membranes and restoring their structural integrity

Hypoglycemia risk (especially if used with insulin or sulfonylureas in patients with diabetes): monitoring and medication adjustment may be needed

As of January 2026, only 13 states provided Medicaid coverage for GLP-1 medications for obesity treatment down from 16 states in 2025, largely due to budget pressure from federal funding changes